Abstract
<i>Rumex acetosa</i> significantly inhibits the adhesion of <i>Porphyromonas gingivalis</i> (<i>P. g.</i>) to eukaryotic host cells <i>in vitro</i>. The objective of this randomized placebo-controlled pilot-trial was to analyze effects of a mouth rinse containing 0.8% (w/w) of a quantified proanthocyanidin-enriched extract from <i>Rumex acetosa</i> (RA1) on microbiological, clinical, and cytological parameters in systemically healthy individuals without history of periodontitis, harboring <i>P. g.</i> intraorally. 35 subjects received a supragingival debridement (SD) followed by mouth rinsing (3 times daily) with either RA1 mouth rinse solution (test) or placebo (control) for 7 days as adjunct to routine oral hygiene. Supragingival biofilm samples were taken at screening visit, baseline (BL), 2, 4, 7 and 14 days after SD. <i>P. g.</i> and 11 other oral microorganisms were detected and quantified by rtPCR. Changes in the oral microbiota composition of one test and one control subject were assessed via high throughput 16S rRNS gene amplicon sequencing. Approximal Plaque Index (API) and the modified Sulcular Bleeding Index (SBI) were assessed at BL, 7- and 14-days following SD. Brush biopsies were taken at BL and 14 d following SD. Intergroup comparisons revealed no significant microbiological, cytological, and clinical differences at any timepoint. However, a significant reduction in SBI at day 14 (<i>p </i>= 0.003) and API at day 7 (<i>p </i>= 0.02) and day 14 (<i>p </i>= 0.009) was found in the test group by intragroup comparison. No severe adverse events were observed. The results indicate that RA1 mouth rinse is safe but does not seem to inhibit colonization of <i>P. g.</i> or improve periodontal health following SD.
Introduction
Periodontitis is a chronic inflammatory disease driven by specific "keystone pathogens," most notably Porphyromonas gingivalis (P. g.). This bacterium utilizes sophisticated adhesion mechanisms to colonize oral surfaces and induce dysbiosis. While broad-spectrum antimicrobials like chlorhexidine are effective, they often carry side effects and contribute to antibiotic resistance. This study investigates a pathobiont-specific approach using a proanthocyanidin-enriched extract from Rumex acetosa (RA1), which has demonstrated significant anti-adhesive properties against P. g. in laboratory settings.
Methods
This randomized, placebo-controlled, double-blind pilot trial enrolled 35 healthy individuals confirmed as intraoral carriers of P. g.. Following a professional supragingival debridement (SD) to reset the oral biofilm, participants were randomized to rinse three times daily for seven days with either a 0.8% RA1 mouthwash (test group, n=18) or a placebo (control group, n=17).
Clinical parameters, including the Approximal Plaque Index (API) and modified Sulcular Bleeding Index (SBI), were assessed at baseline (BL), day 7, and day 14. Microbiological samples were collected at screening, BL, and days 2, 4, 7, and 14 (V1-V6) to quantify P. g. and 11 other oral microorganisms via rtPCR.
Results
The primary microbiological analysis revealed no significant differences between the RA1 and placebo groups regarding the prevalence or quantity of P. g. at any time point.
However, intragroup comparisons showed significant clinical improvements within the RA1 group. Specifically, a significant reduction in SBI was observed at day 14 ($p = 0.003$), and API was significantly reduced at day 7 ($p = 0.02$) and day 14 ($p = 0.009$) compared to baseline. These sustained improvements were not observed in the placebo group. Cytological analysis confirmed that the RA1 extract was safe and non-toxic to human oral cells.
Discussion
The discrepancy between the strong in vitro anti-adhesive effects of RA1 and the lack of significant in vivo microbiological impact highlights the complexity of the oral environment. Bacteria may employ compensatory adhesion mechanisms when faced with anti-adhesive pressure. Despite the lack of intergroup microbiological differences, the clinical improvements in plaque and bleeding indices suggest potential benefits of RA1 as an adjunct to professional cleaning. Future studies with larger cohorts and longer durations are needed to further evaluate its efficacy in diseased populations.
Conclusion
While the RA1 mouth rinse is safe and well-tolerated, it did not significantly inhibit the recolonization of P. g. following debridement in this pilot study. Its role in maintaining periodontal health warrants further investigation.
Summary updated